Keystone Symposia announces virtual ePanel on drug discovery

Keystone Symposia is pleased to announce that it will host a free ePanel discussion on April 26, 2018 at 2:30 PM EST/6:30 PM BST.

Go to the profile of MedChemNet
Apr 23, 2018
0
0
Like 0 Comment

Keystone Symposia on Molecular and Cellular Biology is holding a free virtual webcast on Drug Discovery: Current Trends in Medicinal Chemistry on April 26 2018 at 2:30 PM EST/6:30 PM BST. Dr Walter Moos (ShangPharma Innovation, CA, USA) will lead a roundtable discussion with four experts from biopharma on the challenges, pitfalls and opportunities in drug discovery today.

Topics of discussion include:

  • How well do lead-finding technologies work compared to classical medicinal chemistry techniques?
  • What potential is there for products such as peptides, proteins, antibodies and RNA-based therapies in light of the fact that nearly all the most prescribed therapeutics remain small molecule drugs?
  • What is the optimal balance of in-house R&D vs outsourced work (e.g. CROs) throughout the drug discovery process?
  • How can industry build more symbiotic partnerships with academia?

Panelists will answer audience questions live at the end of the panel discussion; you can submit a question when registering, via the chat room or on Twitter using the hashtag #VKSdrugdisc.

Registration is free at: bit.ly/VKSdrugdisc 
Watch a preview at: bit.ly/VKSdrugdiscpreview

Moderator:

  • Walter H. Moos, ShangPharma Innovation and University of California, San Francisco

Panelists: 

  • Gina Xiaojing Wang, Genentech, Inc. (CA, USA)
  • Dmitry O. Koltun, Gilead Sciences, Inc. (CA, USA)
  • Chudi Ndubaku, Aduro Biotech, Inc. (CA, USA) 
  • Eric B. Harstad, Theravance Biopharma (CA, USA; joining for the Q&A)
Go to the profile of MedChemNet

MedChemNet

A network for the medicinal chemistry community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.